Cue Biopharma, Inc.CUENASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank70
3Y CAGR-20.6%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
-20.6%/yr
Annual compound
Percentile
P70
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$357000.00-55.2%
2024$796000.00-36.1%
2023$1.25M+74.4%
2022$713815.00-
2021$0.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-